Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Lexicon Pharmaceuticals (LXRX) over the last 16 years, with Dec 2024 value amounting to -$1.2 million.

  • Lexicon Pharmaceuticals' Other Working Capital Changes rose 350.76% to $2.7 million in Q4 2012 from the same period last year, while for Dec 2012 it was -$2.6 million, marking a year-over-year decrease of 200.69%. This contributed to the annual value of -$1.2 million for FY2024, which is 139.74% down from last year.
  • Lexicon Pharmaceuticals' Other Working Capital Changes amounted to -$1.2 million in FY2024, which was down 139.74% from $2.9 million recorded in FY2023.
  • Over the past 5 years, Lexicon Pharmaceuticals' Other Working Capital Changes peaked at $2.9 million during FY2023, and registered a low of -$2.9 million during FY2021.
  • For the 3-year period, Lexicon Pharmaceuticals' Other Working Capital Changes averaged around $363,667, with its median value being -$656,000 (2022).
  • As far as peak fluctuations go, Lexicon Pharmaceuticals' Other Working Capital Changes slumped by 248.10% in 2021, and later skyrocketed by 541.92% in 2023.
  • Yearly analysis of 5 years shows Lexicon Pharmaceuticals' Other Working Capital Changes stood at $1.9 million in 2020, then plummeted by 248.10% to -$2.9 million in 2021, then spiked by 77.26% to -$656,000 in 2022, then spiked by 541.92% to $2.9 million in 2023, then crashed by 139.74% to -$1.2 million in 2024.